Category : Search result: pharmaceutical manufacturing


India's New IT Policy Aims for Broader Growth

India's revised IT policy shifts focus from hardware manufacturing to broader digital ecosystem development, aiming to create a more inclusive and sustainable technology sector by 2027.

How India's Electronics Giants Are Rewiring Strategy

Dixon, Tata Electronics, and other Indian manufacturers are aggressively expanding into component manufacturing through acquisitions and JVs to boost thin margins. India's electronics production is projected to hit ₹44 trillion by 2030.

Phillips Launches Manufacturing Center in Pune

Phillips Machine Tools inaugurates a world-class Manufacturing Expertise Center in Chakan, Pune, accelerating India's transition to smart, sustainable manufacturing. Explore the future of industry today!

Granules India Gets USFDA Approval for Hyderabad Plant

Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.

Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook

Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.

Curis Lifesciences IPO: 17x Subscription on Day 1

Curis Lifesciences' NSE SME IPO witnesses massive investor response with 17.36 times subscription on Day 1. Discover GMP trends, price band details, and why this pharma stock is creating buzz.

India's Manufacturing Boom Faces Tough Repeat

India's manufacturing sector faces significant hurdles in repeating its previous success story. Explore the global economic shifts, domestic infrastructure gaps, and policy challenges threatening the next industrial revolution.

Trump: Deal Reached to Lower Weight Loss Drug Prices

Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.

AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion

British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.

DRI Busts Illegal Alprazolam Factory in Gujarat

In a significant crackdown, the Directorate of Revenue Intelligence dismantled a sophisticated drug factory in Gujarat's Valsad district, seizing massive quantities of Alprazolam worth crores and arresting key operatives.

Novo Nordisk Profit Drops 27%, Cuts 9,000 Jobs

Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.

Page 2 of 4